doi: 10.1136/bmj.c1848.
Rosiglitazone, marketing, and medical science
Affiliations
- PMID: 20375091
- DOI: 10.1136/bmj.c1848
Item in Clipboard
Rosiglitazone, marketing, and medical science
BMJ.
.
No abstract available
Similar articles
-
Rosiglitazone: what went wrong?BMJ. 2010 Sep 6;341:c4848. doi: 10.1136/bmj.c4848. BMJ. 2010. PMID: 20819889 No abstract available.
-
The cardiovascular safety of diabetes drugs--insights from the rosiglitazone experience.N Engl J Med. 2013 Oct 3;369(14):1285-7. doi: 10.1056/NEJMp1309610. Epub 2013 Sep 2. N Engl J Med. 2013. PMID: 23992603 No abstract available.
-
FDA puts rosiglitazone post-marketing trial on hold.BMJ. 2010 Jul 26;341:c4017. doi: 10.1136/bmj.c4017. BMJ. 2010. PMID: 20660507 No abstract available.
-
The rosiglitazone meta-analysis.Rev Cardiovasc Med. 2007 Spring;8(2):123-6. Rev Cardiovasc Med. 2007. PMID: 17603430 Review. No abstract available.
-
Lessons from the Avandia controversy: a new paradigm for the development of drugs to treat type 2 diabetes.Diabetes Care. 2007 Dec;30(12):3141-4. doi: 10.2337/dc07-1908. Diabetes Care. 2007. PMID: 18042753 Review. No abstract available.
Cited by
-
Criminals in the Citadel and Deceit all along the Watchtower: Irresponsibility, Fraud, and Complicity in the Search for Scientific Truth.Mens Sana Monogr. 2012 Jan;10(1):158-80. doi: 10.4103/0973-1229.91426. Mens Sana Monogr. 2012. PMID: 22654391 Free PMC article.
-
Physiotherapy trials for the 21st century: time to raise the bar?J R Soc Med. 2011 Nov;104(11):437-41. doi: 10.1258/jrsm.2011.110109. J R Soc Med. 2011. PMID: 22048674 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
